Corneoscleral necrosis after episcleral au-198 brachytherapy of uveal melanoma

Retina

Volumn 29, Issue 1, 2009, Pages 73-79

  Chaudhry, Imtiaz A ^a   Liu, Mimi ^b   Shamsi, Farrukh A ^a   Arat, Yonca O ^a   Shetlar, Debra J ^a   Boniuk, Milton ^a  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^b CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD 198; GOLD;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER INVASION; CILIARY BODY; CLINICAL EVALUATION; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORNEA NECROSIS; CORNEOSCLERAL NECROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRY EYE; ENUCLEATION; EYE PAIN; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAOCULAR FOREIGN BODY; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; SCLERA DISEASE; TREATMENT DURATION; TREATMENT FAILURE; TUMOR RECURRENCE; TUMOR VOLUME; UVEA MELANOMA; CORNEA; MELANOMA; MIDDLE AGED; NECROSIS; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; SCLERA; TIME; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CORNEA; FEMALE; GOLD RADIOISOTOPES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NECROSIS; RADIATION INJURIES; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERA; TIME FACTORS; UVEAL NEOPLASMS;

EID: 61549128202     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181863f7c     Document Type: Article

References (32)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1998;32:239-251.
3. Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H. The epidemiology of ophthalmic malignancies in New York State. Ophthalmology 1990;97:1143-1147.
4. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br J Ophthalmol 1978;62:420-425.
5. Zimmerman LE, Mclean IW, Foster WD. Statistical analysis of follow up data concerning uveal melanoma, and the influence of enucleation. Ophthalmology 1980;87:557-564.
6. De Potter P, Shields CL, Shields JA. New treatment modalities for uveal melanoma. Curr Opin Ophthalmol 1996;7:27-32.
7. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004;111:977-983.
8. Macfaul PA, Bedford MA. Ocular complications after therapeutic irradiation. Br J Ophthalmol 1970;54:237-247.
9. Char DH, Lonn LI, Magolis LW. Complications of cobalt plaque therapy of choroidal melanoma. Am J Ophthalmol 1977;84:536-541.
10. Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 1999;117:170-177.
11. Foerster MH, Bornfeld N, Schulz U, Wessing A, Meyer-Schwickerath G Complications of local beta radiation of uveal melanoma. Graefe's Arch Clin Exp Ophthalmol 1986;224:336-340.
12. Finger PT. Radiotherapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-232.
13. Boniuk M, Cohen JS. Combined use of a radiation plaque and photocoagulation in the treatment of choroidal melanoma. In: Jakobiec FA, ed. Ocular and Adnexal Tumors. Birmingham: Aesculapius Publishing Co.; 1978:80-85.
14. Moura RA, McPherson AR, Easley J. Malignant melanoma of the choroid: treatment with episcleral 198Au plaque and xenon-arc photocoagulation. Ann Ophthalmol 1985;17:114-125.
15. Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S. Ruthenium brachytherapy for uveal melanoma, 1979-2003. Survival and functional outcomes in the Swedish population. Ophthalmology 2005;112:834-840.
16. Finger PT, Berson A, Szechter A. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study. Ophthalmology 1999;106:606-613.
17. Lommatzsch PK. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience. Br J Ophthalmol 1986;70:844-851.
18. Puusaari I, Heikkonen J, Kivela T. Ocular complications after Iodine brachytherapy for large uveal melanoma. Ophthalmology 2004;111:1768-1777.
19. Shields CL, Shields JA, Karlsson U, Markoe AM, Brady LW. Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Ophthalmology 1989;96:919-924.
20. Khan FM. Brachiotherapy. In: Khan FM, ed. The Physics of Radiation Therapy. 2nd ed. Philadelphia: William & Wilkins; 1994;418-470.
21. Correa ZM, Augsburger JJ, Freire J, Eagle RC. Early-onset scleral necrosis after Iodine I 125 plaque radiotherapy for cilio-choroidal melanoma Arch Ophthalmol 1999;117:259-261.
22. Messmer E, Bornfeld N, Foerster M, Schilling H, Wessing A. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefe's Arch Clin Exp Ophthalmol 1992;230:391-396.
23. O'Donohue E, Lightman S, Tuft S, Watson P. Surgically induced necrotizing sclerokeratitis (SINS): precipitating factors and response to treatment. Br J Ophthalmol 1992;76:17-21.
24. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition. COMS Report No. 3. Control Clin Trials 1993;14:362-373.
25. Collaborative Ocular Melanoma Study Group. Collaborative Ocular Melanoma Study randomized trial of iodine 125 brachytherapy for choroidal melanoma. III: Initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119: 969-982.
26. Collaborative Ocular Melanoma Study Group. Histopathologic characteristics of uveal melanoma in eyes enucleated from the collaborative ocular melanoma study. COMS Report No. 6. Am J Ophthalmol 1998;125:745-766.
27. Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Sever corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol 1993;111:947-951.
28. Casas VE, Kheirkhah A, Blanco G, Tseng SC. Surgical approach for scleral ischemia and melt. Cornea 2008;27:196-201.
29. Sangwan VS, Jain V, Gupta P. Structural and functional outcome of scleral patch graft. Eye 2007;21:930-935.
30. Oh JH, Kim JC. Repair of scleromalacia using preserved scleral graft with amniotic membrane transplantation. Cornea 2003;22:288-293.
31. Rodriguez-Ares MT, Tourino R, Capeans C, Sanchez-Salorio M. Repair of scleral perforation with preserved scleral amniotic membrane in Marfan's syndrome. Ophthalmic Surg Lasers 1999;30:485-487.
32. Lin CP, Tsai MC, Wu YH, Shih MH. Repair of a giant scleral ulcer with preserved sclera and tissue adhesive. Ophthalmic Surg Lasers 1996;27:995-999.